Events

Upcoming Events

06 June 2012 – Lunch Debate: Opening up medical research data for an ethical and efficient EU policy

Crucial information about many medicines is kept secret. In consequence, doctors can face difficulty in choosing the safest and most effective treatment for their patients. Is it ethical and efficient for the EU to allow essential medical research data to be shrouded in secrecy? Can the health of EU citizens be effectively protected with very little or insufficient access to clinical trial data concerning the safety and secondary effects of a drug?

• Programme

Past Events

30 November 2011 – Horizon 2020: Investing in the common good

At the same time as the European Commission presented its Research and Innovation Framework programme – Horizon 2020, Health Action International (HAI) Europe and Trans Atlantic Consumer Dialogue (TACD) organized an expert conference to examine how this proposal will invest 80 billion Euros of taxpayers’ money in economically and socially sustainable innovation models. The present financial crisis calls for bold experimentation with new innovation models that guarantee more openness, easier accessibility and higher result-oriented efficiency.

• Event Memo
• Programme
• Press release

24 September 2011 – Mad Medicine: Do conflicts of interest drive you crazy?

HAI Europe Open Seminar in cooperation with the Critical Voices Network Ireland in Cork, Ireland

Speakers:

• Ivor Browne (Critical Voices Network Ireland) Mental Illness- the Great Illusion?
• Lisa Cosgrove (University of Massachusetts- Boston) Conflicts of Interest and the Diagnostic and Statistical Manual of Mental Disorders
• Adriane Fugh-Berman (PharmedOut and Georgetown University) Conflicts of interest in drug promotion and more
• David Healy (Cardiff University) The Cardinals of Psychiatry presentation notes
• Agnes Higgins (Irish Institute of Mental Health Nursing) Case studies of potential conflicts of interest issues arising in Irish psychiatric medicine
• John McCarthy (Critical Voices Network Ireland) Mad Pride sound clip
• Barbara Mintzes (University of British Columbia) Conflicts of interest in regulation and the meaning of “effectiveness” and “safety”
• Richard Patterson (Critical Voices Network Ireland) Part 1 Part 2 Part 3 Part 4 Part 5
• Noel Wathion (European Medicines Agency) The European Medicines Agency Handling of Conflicts of Interests

4 August 2011 – ASEFUAN Academic Conference Amsterdam, The Netherlands

• HAI Europe Presentation: Essential Innovation and Access to Medicines: towards new models of research and development (Part 1) (Part 2)
  

4 – 8 July 2011 – Utrecht University/WHO Collaborating Center Policy Analysis Summmer Course

• HAI Europe Presentation: Transparency of European medicines regulation

23 – June 2011 – Farmamundi Meeting, Valencia, Spain

• HAI Europe Presentation: The influence of advertising in medicines use (Part 1) (Part 2) (Part 3)
  

6 May 2011 - ASEFUAN / IGIR Dialogue on Trade and Competition in the Global Pharmaceutical Industry

• Consumer perspectives on Intellectual Property, Competition & Access to Medicines in Europe

13 Apr 2011 – EPSA Annual Congress - HAI Europe Workshop – Medicines Information:Independent or Promotional?

• Workshop Information Package
• Healthcare Professionals and Promotional Material
• Medicines Information: Independent or Promotional? (Part 1/Part 2)

18 Nov 2010 – European Parliament – Can We Afford the Current Model of Medical Innovation? Towards New Models of Innovation

• Concept Note
• Event Memo
  

2 Dec 2009 – Expert Meeting – A closer look at the legislative proposals on ‘information’ to patients

• What is the added value?
• The information to patients directive: déjà vu all over again
• Patients’ information expectations : The case of French IBD patients
• Information to patients on prescription medicines: What do older people expect from the EU
• Industry as information provider – bias for free?

14 Nov 2009 – Medicines in Poland Workshop Series – Independent Medicines Information

• Event Memo
• Understanding and Responding to Pharmaceutical Promotion- A Practical Guide (PL / EN)
• Challenge to independent information – The Information to Patients’ Directive (PL / EN)
• Unbiased medicines’ information European best practices (PL / EN)
• Factsheet – Medicines Reimbursement in Poland

12 Nov 2009 – Medicines in Poland Workshop Series – Improved Medicines’ Reimbursement

• Event Memo
• Poland’s Reimbursement System: Strengths & Weaknesses (PL / EN)

23 Oct 2009 – HAI Europe Open Seminar – EU Policy in Action: In Whose Interest?

• Programme
• Participants List
• Speaker Biographies
• Speaker Abstracts
• The European Union and Access to Medicines
• EU Pharmaceutical Policy
• The EU Pharmacovigilance Proposals
• Impact of EU-CAN Trade Agreement on Access to Medicines: Research Findings

15-16 Oct 2009 – Medicines in Portugal Workshop Series – Access and Reimbursement

• Event Memo
• Event Programme
• Portugal’s Reimbursement System: Critical Assessment of the Access to Essential Medicines (PT / EN)
• Advocacy on Medicines Issue (PT/EN)
• Setting Up an Independent Drug Bulletin – Best Practices in Unbiased Medicines’ Information (PT/EN)

17 Feb 2009 – Expert Meeting - Access to medicines in jeaopardy

• Event Memo
• Concept Note
• Presentation Summaries
• Programme
  

21 Nov 2008 – HAI Europe Open Seminar – Clinical Trials on Trial

• Programme
• Participants List
• Change Can Happen: New Trends in Clinical Trials in the U.S.
• Clinical Trials as Marketing: The Case of Obesity
• The Golden Standard or Fool’s Gold: Selective Data, Impact on Safety
• Clinical Trials In Developing Countries
• Addressing Diversity In CTs
• Clinical Trials on Trial: The Patient Perspective

12 Oct 2007 – HAI Europe Open Seminar – Ensuring Independent Medicines Information in Europe

• Programme
• Seminar Report
• Information to Patients: Putting Patients First
• You say information,I say advertising… Pharmaceutical Policy in Europe
• Information to Patients in Europe, The Pharmaceutical Forum as One of The Drivers For Change?
• Patient Information: A Delicate Balance
• Direct To Consumer Information
• Disease Awareness – Promotion In Disguise
• The View of The British Medical Profession on the Provision of Information
• Promotion Of Unbiased Information
• The Role Of Industry in The Provision Of Information
• New Is Not Always Better

26-27 Oct 2006 – HAI Europe 25th Anniversary Conference – Pill, Politics and Practice: Demanding People-Centred Medicines Policy in the 21st Century

• Programme
• Consumer and Patient Participation in Influencing Drug Policies in China
• Research-Based Consumer Advocacy: Data Analyses Facilitate Early Warnings to Patients, Withdrawals of Dangerous Drugs
• FTA USA-Peru and Access to Medicines
• The Challenges of Pharmacovigilance
• Joint Declaration: Relevant Health Information for Empowered Citizens
• Paying the Price
• Disease-Mongering Selling Sickness
• Public-Private Interactions: Successes, Failures and Cautions
• Commercial Myths, Drug Promotion, and Public Health: 1981 to 2006
• Civil Society Interventions on Medicines Policy in the African Region
• The WTO TRIPS Agreement, Innovation and Access to Medicines: Does the Emperor Have Any Clothes on at All?

Noël Wathion (European Medicines Agency) Conflicts of Interest Policy and the EMA